Mar. Drugs 2014, 12(3), 1623-1640; doi:10.3390/md12031623
Article

Largazole Pharmacokinetics in Rats by LC-MS/MS

1,5email, 2,6email, 1email, 1email, 1email, 2,3email, 2,3email, 4email, 1,3email and 2,3,* email
Received: 14 October 2013; in revised form: 30 January 2014 / Accepted: 27 February 2014 / Published: 20 March 2014
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: A highly sensitive and specific LC-MS/MS method for the quantitation of largazole thiol, the active species of the marine-derived preclinical histone deacetylase inhibitor, largazole (prodrug), was developed and validated. Largazole thiol was extracted with ethyl acetate from human or rat plasma along with the internal standard, harmine. Samples were separated on an Onyx Monolithic C18 column by a stepwise gradient elution with 0.1% formic acid in methanol and 0.1% aqueous formic acid employing multiple reaction monitoring (MRM) detection. Linear calibration curves were obtained in the range of 12.5–400 ng/mL with 200 µL of human plasma. The overall intra-day precision was from 3.87% to 12.6%, and the inter-day precision was from 7.12% to 9.8%. The accuracy at low, medium and high concentrations ranged from 101.55% to 105.84%. Plasma protein bindings of largazole thiol in human and rat plasma as determined by an ultrafiltration method were 90.13% and 77.14%, respectively. Plasma drug concentrations were measured by this LC-MS/MS method. The pharmacokinetics of largazole thiol in rats was studied following i.v. administration at 10 mg/kg and found to follow a two-compartment model. Largazole thiol was rapidly eliminated from systemic circulation within 2 h. The established LC-MS/MS method is suitable for the analysis of largazole thiol in human plasma, as well.
Keywords: largazole; LC-MS/MS; pharmacokinetics; protein binding
PDF Full-text Download PDF Full-Text [1409 KB, uploaded 20 March 2014 11:38 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Yu, M.; Salvador, L.A.; Sy, S.K.B.; Tang, Y.; Singh, R.S.P.; Chen, Q.-Y.; Liu, Y.; Hong, J.; Derendorf, H.; Luesch, H. Largazole Pharmacokinetics in Rats by LC-MS/MS. Mar. Drugs 2014, 12, 1623-1640.

AMA Style

Yu M, Salvador LA, Sy SKB, Tang Y, Singh RSP, Chen Q-Y, Liu Y, Hong J, Derendorf H, Luesch H. Largazole Pharmacokinetics in Rats by LC-MS/MS. Marine Drugs. 2014; 12(3):1623-1640.

Chicago/Turabian Style

Yu, Mingming; Salvador, Lilibeth A.; Sy, Sherwin K.B.; Tang, Yufei; Singh, Ravi S.P.; Chen, Qi-Yin; Liu, Yanxia; Hong, Jiyong; Derendorf, Hartmut; Luesch, Hendrik. 2014. "Largazole Pharmacokinetics in Rats by LC-MS/MS." Mar. Drugs 12, no. 3: 1623-1640.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert